• MindWave Innovations recently advanced its Bitcoin treasury strategy with up to $100M PIPE and activation of 1,000 BTC, accelerating institutional adoption of AI-driven digital asset infrastructure
• The company operates at the intersection of insured custody, AI yield engines, and board-governed segregated treasury structures
• These developments reinforce MindWave’s mission: providing institutional-grade treasury infrastructure for the digital asset economy

MindWave Innovations (NYSE American: APUS) is strategically positioning itself at the forefront of a structural shift in corporate finance: the transition from static treasury holdings to intelligent, yield-generating digital asset infrastructure. As companies increasingly follow the path pioneered by MicroStrategy and newer institutional adopters, the demand for compliant, secure, and yield-optimized Bitcoin treasury systems has intensified. 

The company’s latest milestone, up to $100 million PIPE financing alongside the activation of 1,000 BTC, highlights increasing investor conviction in Bitcoin not just as a store of value, but as a productive treasury instrument when paired with institutional-grade infrastructure (ibn.fm/LFt2j). Unlike what is obtainable with traditional corporate treasuries that depend on cash equivalents or short-duration government securities yielding modest returns, MindWave’s model introduces programmable yield strategies anchored in digital markets.

At the nucleus of MindWave’s architecture is its insured custody and segregated treasury framework. Assets are held in institutional custody environments with layered insurance protections and board-controlled structures that ensure separation of strategic, operational, and custodial authority. This structure is made to meet the expectations of corporate finance teams while maintaining exposure to digital asset upside.

Beyond custody, MindWave’s AI-powered yield engine differentiates its platform in a quickly evolving ecosystem. The system dynamically allocates capital across derivatives positioning, liquidity provisioning in decentralized markets, and volatility-based trading strategies designed to extract non-directional returns from Bitcoin markets. Unlike what is obtainable with speculative trading, these strategies are structured around drawdown controls, risk parameters, and capital preservation models aligned with institutional mandates. 

Also, MindWave integrates validator node infrastructure, making it possible for corporations to participate in blockchain network validation mechanisms that generate protocol-level yield. This approach introduces a third dimension of treasury performance, operational yield derived from network participation, expanding beyond simple price appreciation.

The importance of this model becomes clearer when compared to traditional treasury instruments. While American Treasury bills and money market funds typically offer single-digit yields constrained by macroeconomic cycles, Bitcoin treasury strategies enhanced by AI-driven infrastructure introduce a hybrid return profile combining asset appreciation potential with active yield generation. However, MindWave emphasizes that such strategies are built with risk-aware architecture rather than unchecked leverage or directional exposure.

By ensuring transparent reporting systems, the company intends to tackle one of the most pressing institutional concerns: control and accountability in digital asset management. This places MindWave as not just a crypto-adjacent tech provider, but also as a treasury infrastructure partner for corporations entering the digital asset economy.

As institutional adoption of Bitcoin speeds up worldwide, MindWave Innovations is betting on a future where corporate treasuries evolve into intelligent capital systems, capable of optimizing, adapting, and generating yield in real time. For corporate finance leaders and digital asset investors alike, the company’s approach signals a potential redefinition of what treasury management looks like in the era of programmable money.

For more information, visit the company’s website at www.MindWaveDAO.com.

NOTE TO INVESTORS: The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS

• OTLC continues to advance its Deciparticle nanomedicine platform, with expanding international development initiatives supporting future therapeutic and commercial opportunities.
• The company’s PDAOAI ecosystem now incorporates 28 million scientific abstracts and is being deployed into real-world pharmaceutical automation applications through TechForce Robotics.
• The company is leveraging AI, nanomedicine, and automation to accelerate therapies for cancer and rare diseases.

Oncotelic Therapeutics (OTCQB: OTLC) is strategically placing itself at the nexus of precision oncology, advanced automation, and artificial intelligence. Through its PDAOAI artificial intelligence ecosystem, Deciparticle(TM) nanomedicine platform, and emerging robotics initiatives, the company is quickly building an integrated technology portfolio built to improve the way therapies are developed, manufactured, and delivered to patients suffering from some of the most difficult-to-treat diseases (ibn.fm/lU39h).

A critical aspect of the company’s strategy is its Deciparticle(TM) platform, developed through its relationship with Sapu Nano. The technology is created to address longstanding challenges associated with hydrophobic drugs, which usually suffer from poor solubility, limited bioavailability, and dose-limiting toxicities. By formulating therapeutics into ultra-small nanoparticles measuring less than 20 nanometers, Deciparticle(TM) seeks to improve intravenous delivery, enhance tissue penetration, and enable more precise tumor targeting.

The platform is advancing through multiple programs, including Sapu003, an intravenous formulation of Sapu006, a pilysorbate-free intravenous docetaxel formulation, and everolimus. According to company data, Deciparticle(TM) technology can formulate a broad range of challenging compounds while maintaining consistent nanoparticle size and stability (ibn.fm/iTfEQ). The company believes these capabilities could help create opportunities across immunology, oncology, and peptide therapeutics.

Momentum behind the platform continues to build. Recently, Sapu Nano announced an expansion of its international development strategy designed to accelerate advancement of Deciparticle-enabled therapeutic candidates and broaden potential commercialization opportunities. The initiative underscores growing confidence in the platform’s applicability across multiple drug classes while supporting Oncotelic’s objective of developing scalable solutions for difficult-to-formulate compounds.

“This platform advances beyond single-asset value to a multi-asset opportunity across oncology, immunology, and peptide therapeutics. Sapu003 is only the beginning,” said Vuong Trieu, Chief Executive Officer of Sapu Nano.

Beyond drug delivery, Oncotelic is leveraging AI to create a scalable knowledge development ecosystem. The company’s proprietary PDAOA platform recently attained a significant milestone with the successful integration of about 28 million scientific abstracts, representing a vast repository of scientific knowledge. The platform is specially designed to organize, analyze, and apply this information to support translational research, therapeutic development, and operational decision-making.

The company is now extending those capabilities into commercial applications through its jointly developed robotics platform with TechForce Robotics. By embedding scientific knowledge directly into automated workflows operating in regulated pharmaceutical environments, the platform is created to improve efficiency, cut down reliance on manual processes, and support compliance throughout manufacturing and development operations.

The collaboration recently advanced with TechForce Robotics’ formal entry into pharmaceutical automation, marking an important step toward deploying AI-enabled robotic systems within regulated life sciences environments. The initiative reflects Oncotelic’s broader vision of combining artificial intelligence, scientific knowledge management, and automation to create integrated solutions that can streamline drug development and manufacturing workflows.

“We are moving from data to real-world application,” said Dr. Vuong Trieu, Chairman and Chief Executive Officer of Oncotelic. “By embedding the totality of scientific knowledge into robotics, we can look to transform how drugs are developed and produced, not just for us, but for the broader industry.”

Initial deployments are expected as the company pushes toward the broader commercialization and prepares to scale production capabilities to support expected demand.

These technology initiatives perfectly complement Oncotelic’s therapeutic pipeline, which focuses on areas of substantial unmet need, including orphan oncology indications.

The company’s leading candidate, OT-101, targets TGF-beta signaling and has received orphan-focused designations for Diffuse Intrinsic Pontine Glioma (“DIPG”), a devastating pediatric brain cancer with limited treatment options.

Taken together, the continued advancement of the Deciparticle platform, the expansion of international development initiatives through Sapu Nano, and the progression of AI-powered pharmaceutical automation with TechForce Robotics highlight Oncotelic’s strategy of building value across multiple complementary technologies. While OT-101 and the company’s oncology pipeline remain central to its therapeutic ambitions, the combination of AI, advanced nanomedicine, and robotics positions OTLC to participate in several high-growth segments of healthcare innovation, potentially creating multiple pathways for future commercialization and long-term value creation.

For more information, visit the company’s website at www.Oncotelic.com.

NOTE TO INVESTORS: The latest news and updates relating to OTLC are available in the company’s newsroom at ibn.fm/OTLC

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

• MindBio Therapeutics is developing AI-powered voice analysis technology designed to detect drug and alcohol impairment from short speech samples.
• The platform analyzes more than 140 acoustic markers and has been trained on a dataset exceeding 50 million data points.
• Mining operations in South America represent the company’s initial commercial focus, where workforce safety and high-volume screening requirements create operational challenges.
• Potential applications extend beyond mining into aviation, construction, law enforcement, call centers, transportation, and mental health settings.
• The global alcohol and drug testing devices market is projected to grow from approximately $2.5 billion in 2025 to $4.2 billion by 2033.
• MindBio’s approach seeks to provide a faster, less invasive alternative to traditional breath, saliva, urine and laboratory-based testing methods.

Workplace impairment testing remains an essential component of risk management across many industries, but the methods used today have changed relatively little over the past several decades. Employers continue to rely heavily on breathalyzers, saliva tests, urine screening and laboratory analysis to identify alcohol and drug impairment. While effective, these methods can be expensive, time-consuming and difficult to scale across large workforces. That challenge is becoming increasingly relevant as regulators and employers place greater emphasis on workplace safety, compliance and operational efficiency.

Against this backdrop, MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company, is developing a technology platform that takes a different approach. The company has spent several years conducting drug and alcohol research while building artificial intelligence and machine-learning models designed to estimate intoxication levels through speech analysis. Rather than requiring biological samples, the platform analyzes voice recordings captured through standard microphones.

According to the company, its system evaluates more than 140 acoustic markers and has been trained using more than 50 million data points collected through extensive research programs. The objective is straightforward: identify measurable changes in speech associated with alcohol or drug impairment and generate an assessment in real time.

The commercial opportunity surrounding that capability may be substantial. The global alcohol and drug testing devices market is expected to expand from approximately $2.5 billion in 2025 to $4.2 billion by 2033 as employers adopt new safety technologies and regulatory requirements continue to evolve (https://ibn.fm/88jXn). 

The need extends well beyond regulatory compliance. In industries such as mining, aviation, transportation and construction, impairment screening is often mandated because employees operate heavy equipment, work in hazardous environments or perform safety-sensitive tasks where mistakes can carry significant consequences.

Large organizations may process hundreds or thousands of workers each day, creating logistical challenges when traditional testing methods are used. MindBio believes artificial intelligence can help address that issue. The company is developing Edge AI kiosk systems designed to collect short voice samples from workers entering a facility. Within seconds, the system could potentially identify indicators of impairment and flag individuals requiring further evaluation.

This process would replace traditional screening models that are time consuming, unhygienic and expensive on a per test basis. This new category changing testing solution may function as a rapid screening layer that helps employers allocate resources more efficiently while reducing operational bottlenecks.

Mining has emerged as the company’s initial target market. Many mining operations, particularly in South America, involve remote sites, rotating workforces and physically demanding environments where safety monitoring is critical and drug and alcohol consumption is a major problem. Traditional testing programs can become expensive and administratively burdensome when deployed across large numbers of employees.

MindBio has indicated that field testing of its kiosk technology is expected during 2026, providing an important opportunity to evaluate performance in real-world industrial settings.

The potential market extends well beyond mining. The company has previously highlighted aviation and construction as logical applications because both sectors already operate within regulatory frameworks that require impairment management and workforce monitoring. In aviation, rapid screening tools could potentially assist operators managing large employee populations across multiple facilities. Construction companies face similar challenges, particularly on large infrastructure projects where contractors, subcontractors and temporary workers may need to be screened efficiently.

Another area attracting attention is call-center operations. While call centers are not typically associated with physical safety risks, employers increasingly monitor employee performance, wellness and productivity. Because communication occurs almost entirely through speech, voice analytics may provide additional insights regarding impairment, fatigue or behavioral changes.

Mental health and healthcare settings present another potential use case. Voice analysis has increasingly been studied as a tool for identifying changes in emotional state, stress levels and cognitive function. While MindBio’s primary focus remains intoxication detection, the broader field of speech analytics continues to attract interest from researchers exploring non-invasive health monitoring technologies.

Law enforcement may also represent a future opportunity. Officers frequently encounter situations where immediate assessment of impairment would be valuable, yet laboratory testing may not be readily available. A rapid voice-based screening tool could potentially serve as an additional assessment mechanism.

What differentiates MindBio from many technology companies entering workplace safety markets is the foundation of its research. The company’s machine-learning models are derived from years of drug and alcohol studies, creating datasets specifically designed to examine the relationship between speech patterns and impairment. Management believes that proprietary data may become a significant competitive advantage as artificial intelligence applications expand across healthcare and enterprise markets.

For more information, visit the company’s website at www.MindBioTherapeutics.com. 

NOTE TO INVESTORS: The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

• Today many mining projects are designed with a wider development mandate, recognizing that infrastructure can generate benefits extending well beyond the life of a mine.
• Numa Numa Resources has positioned infrastructure development as a central component of its strategy.
• The company’s infrastructure efforts are occurring alongside agreements with landowners connected to the Panguna resource area.

Modern mining projects are no longer judged solely by the minerals they produce. Increasingly, companies are being evaluated on the roads they build, the power systems they create and the long-term economic opportunities they leave behind. In Bougainville, Numa Numa Resources is pursuing this broader approach, combining resource development ambitions with infrastructure investments designed to reconnect communities and support future growth.

The relationship between mining and infrastructure has existed for generations, but the nature of that relationship has evolved significantly. Historically, mining companies often built infrastructure primarily to support extraction activities. Roads, railways, ports and power facilities were constructed to move equipment and transport ore. Today, however, many mining projects are designed with a wider development mandate, recognizing that infrastructure can generate benefits extending well beyond the life of a mine.

This shift reflects both practical business considerations and changing stakeholder expectations. The World Bank has noted that infrastructure associated with extractive industries can contribute to broader economic development when planned and managed effectively, helping improve transportation networks, energy access and connectivity for surrounding communities. Better infrastructure can reduce operating costs for mining companies while simultaneously creating new opportunities for local businesses, healthcare providers, schools and residents.

The importance of infrastructure is particularly evident in remote regions where transportation and energy access remain limited. Studies show that infrastructure investments are often critical components of resource development projects because they support both industrial activity and wider economic participation. Roads can connect isolated populations to markets and services, while power systems can support new industries that continue operating long after mining activities conclude.

Lessons learned from past mining projects have also influenced this evolution. In regions where mining operations were associated with social conflict, environmental concerns or disputes over economic benefits, communities increasingly expect developers to demonstrate broader commitments to local development. Industry organizations such as the International Council on Mining and Metals emphasize the importance of social performance and community engagement as essential elements of modern mining operations.

Bougainville provides a compelling example of why these issues matter. The region’s history is closely tied to the Panguna Mine, which began production in 1972 and became one of the world’s largest copper and gold mines. At its peak, the operation generated a significant portion of Papua New Guinea’s export revenue, according to research published by the Australian National University’s Devpolicy program. However, disputes involving environmental impacts, land ownership and revenue distribution contributed to tensions that ultimately helped fuel the Bougainville conflict, which lasted from 1988 to 1998.

In the years since the Bougainville Peace Agreement was signed in 2001, the region has focused on rebuilding institutions, infrastructure and economic opportunities. Any future resource development efforts must navigate this history while demonstrating how projects can create value for local communities.

Within this context, Numa Numa Resources has positioned infrastructure development as a central component of its strategy. According to the company, one of its most significant initiatives is the construction of the first east-west road across Bougainville’s mountainous central mining district since before the civil conflict. The project is designed not only to support potential mining activities but also to improve transportation access across an area that has remained difficult to traverse for decades.

For isolated communities, transportation infrastructure can have transformative effects. Roads can reduce travel times, improve access to healthcare and education, lower the cost of goods and services and facilitate economic activity. In many developing regions, transportation corridors become catalysts for broader growth by enabling agricultural production, trade and entrepreneurship.

Numa Numa’s infrastructure efforts are occurring alongside agreements with landowners connected to the Panguna resource area. For example, since the Panguna area remains off the grid in the aftermath of the civil conflict, the company was authorized by the government to conduct feasibility studies for the development and construction of a renewable energy based (hydroelectric, solar, and battery power), integrated electric utility to bring electricity back to the region. The company is working with customary landowners to support future development of what it describes as an estimated $100 billion copper and gold resource opportunity. While the ultimate economic value of any mineral deposit depends on commodity prices, technical assessments and development outcomes, the scale of the resource has long attracted international attention.

The company’s emphasis on collaboration reflects broader trends in second-generation mining projects. Rather than focusing exclusively on extraction, developers increasingly recognize that long-term success depends on building trust, creating shared economic benefits and investing in assets that communities can continue using long after mining operations have ended.

In Bougainville, that philosophy may prove particularly important. The region’s future will likely be shaped not only by the minerals beneath the ground but also by the infrastructure above it. Roads, transportation networks and community investments can provide lasting value that extends beyond resource production itself.

As a result, projects such as those being pursued by Numa Numa Resources illustrate how modern mining is evolving. The focus is no longer simply on what can be extracted, but on what can be built. For Bougainville, infrastructure development may ultimately become one of the most important legacies of resource investment, helping connect communities, expand economic opportunity and support the region’s long-term development goals.

For more information, visit www.NumaNumaResources.com. 

NOTE TO INVESTORS: The latest news and updates relating to Numa Numa are available in the company’s newsroom at https://ibn.fm/NUMA

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

• Traditionally, many significant investment opportunities in the space industry were only accessible to venture capital and institutional investors, leaving retail investors unable to participate.
• However, Planet Ventures Inc. is changing this, as the company provides shareholders with indirect exposure to private space and aerospace companies through a publicly traded investment vehicle.
• A variety of companies stretch under Planet Ventures’ belt, including areas like software, energy, robotics, emerging applications, and infrastructure.

The commercial space economy is entering a new phase of growth. What was once dominated by government agencies is rapidly evolving into a global industry encompassing satellite communications, orbital infrastructure, artificial intelligence, robotics, energy systems, and even lunar development. With industry forecasts projecting the space economy is projected to surpass $1 trillion in value over the coming decades, investors are increasingly looking for ways to participate in this transformation.

Yet many of the most promising opportunities remain inaccessible to everyday investors. Historically, exposure to emerging space companies has largely been reserved for venture capital firms, institutional investors, and private funding networks, leaving retail investors with limited options to gain meaningful participation in the sector’s growth.

Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) is helping bridge that gap. As a publicly traded investment issuer focused on the space and aerospace industries, the company provides investors with indirect exposure to a portfolio of private and early-stage businesses developing technologies that could help shape the future of the next frontier.

Planet Ventures’ strategy centers on identifying innovative companies operating across key segments of the emerging space economy and allocating capital to businesses positioned to benefit from long-term industry expansion. Through this approach, shareholders gain access to opportunities spanning orbital infrastructure, energy systems, artificial intelligence, robotics, and lunar development through a single public-market vehicle.

The company’s portfolio reflects several of the most important themes driving the next generation of space commercialization. Planet Ventures has invested in Relativity Space, a launch infrastructure company led by former Google CEO Eric Schmidt; Mantis Space, which is developing what it describes as the world’s first orbital power grid; and Antaris Inc., whose AI-powered software platform is designed to simplify satellite constellation design, simulation, and operations.

The company has also  made an investment into Galactic Resource Utilization Space Inc., which is pursuing lunar infrastructure and space tourism initiatives, including plans for a lunar hotel; General Astronautics, a developer of autonomous robotics systems for microgravity research and development; and Lux Aeterna, which is building a fully reusable satellite platform designed to support future space operations.

Collectively, these investments provide exposure to several of the technologies expected to underpin the expanding commercial space ecosystem. From orbital energy generation and AI-driven mission management to robotics and lunar infrastructure, Planet Ventures is building a portfolio aligned with the industry’s long-term evolution.

Leading the effort is CEO Etienne Moshevich alongside Executive Director Desmond Balakrishnan and a team of experienced professionals spanning capital markets, finance, technology, and business development. The company recently strengthened its space-focused investment expertise with the appointment of Dr. Bora Uygun as Head of Space Investments. A recognized entrepreneur and active angel investor, Uygun brings extensive experience across aerospace, artificial intelligence, telecommunications, and fintech.

As commercial activity in orbit continues to expand and private capital increasingly drives innovation beyond Earth, Planet Ventures offers retail investors a rare opportunity to gain exposure to private companies operating at the forefront of the space economy through a publicly traded investment platform.

For more information, visit www.PlanetVenturesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to PNXPF are available in the company’s newsroom at https://ibn.fm/PNXPF

Disclaimer

Investor Brand Network (“We” or “Us”) are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Planet Ventures Inc. will make aggregate payments of $100,000  to us to provide marketing services for a term of 1 year. This article is informational only and is solely for use by prospective investors in determining whether to seek additional information. This does not constitute an offer to sell or a solicitation of an offer to buy any securities. Our stock profiles are intended to highlight certain companies for your further investigation; they are not stock recommendations or constitute an offer or sale of the referenced securities. The securities issued by the companies we profile should be considered high risk; if you do invest despite these warnings, you may lose your entire investment. Please do your own research before investing, including reading the companies’ SEDAR+ and SEC filings, press releases, and risk disclosures. 

Forward-Looking Statements

This document contains forward-looking statements within the meaning of applicable securities legislation. Such statements include, without limitation, statements regarding: Planet Ventures’ investment strategy and objectives; anticipated developments in the commercial space industry, including the growth of orbital energy and space robotics markets; the projected growth of the global space economy; Planet Ventures’ expectations regarding the strategic importance of its investments in Mantis Space and General Astronautics; the anticipated role of orbital energy technologies and robotic servicing systems in future in-orbit operations; and the potential for these technologies to become foundational to the next generation of commercial space activity.

Forward-looking statements are not guarantees of future performance. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this document are made as of the date hereof and Planet Ventures undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

Risk Factors

Investing in Planet Ventures and its portfolio companies involves a high degree of risk. The following is a summary of key risk factors. This is not an exhaustive list, and additional risks may exist that are not currently known:

• Early-Stage Investment Risk. Portfolio companies have limited operating histories and are pre-revenue. Investments are speculative and may result in a total loss of capital.
• Technology Risk. The orbital energy and lunar habitation technologies underlying the Company’s investments are unproven at commercial scale and may not be successfully developed or deployed.
• Regulatory Risk. Space sector operations require licenses and approvals from domestic and international regulatory bodies. Failure to obtain or maintain these could materially delay or prevent operations.
• Market Risk. Commercial demand for in-space power systems and lunar services has not been established at scale. Projected market growth may not be realized within anticipated timeframes.
• Liquidity Risk. Investments in private, early-stage companies are illiquid. There is no guarantee of a market for these securities or the ability to exit on favorable terms.
• Capital Risk. Portfolio companies may require additional funding that may not be available, or may be available only on dilutive or restrictive terms.
• Macroeconomic and Geopolitical Risk. Adverse macroeconomic conditions or geopolitical developments could disrupt the Company’s investment strategy or the operations of portfolio companies.
• Key Personnel Risk. The Company’s performance depends in part on retaining key personnel and advisors. Loss of key individuals could adversely affect the Company’s operations and investment activities

• Forward Industries, a Solana (SOL) treasury company that buys, holds, and strategically deploys SOL, has announced that it will soon join the Russell 2000(R) and 3000(R) indexes.
• Forward will join the indexes as a part of Russell indexes semi-annual reconstitution in June, which captures the 3,000 largest US stocks as of April 30, 2026, and ranks them by market capitalization.
• The move is an important milestone for Forward and reinforces the growing institutional recognition of Forward’s Solana treasury strategy.

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently announced that it is set to join both the broad-market Russell 3000(R) Index and the small-cap Russell 2000(R) Index (https://ibn.fm/KcXh1). 

The move is a part of Russell indexes’ semi-annual reconstitution, which is effective once the US market opens on June 29, 2026. This semi-annual reconstitution of the Russell US indexes captures the 3,000 largest US stocks as of April 30, 2026, and ranks them by market capitalization.

Companies that gain membership in the Russell 3000(R) Index also gets them automatic membership in the large-cap Russell 1000(R) Index or small-cap Russell 2000(R) Index, and the appropriate value and growth style indexes. FTSE Russell determines membership for its indexes by objective, style attributes, and market capitalization rankings.

Speaking about Forward’s inclusion in the indexes, Ryan Navi, the Chief Investment Officer at Forward Industries said that “Inclusion in the Russell 2000(R) and Russell 3000(R) marks an important milestone for Forward and reinforces the growing institutional recognition of our strategy, scale, and execution. We believe index inclusion will expand our shareholder base, improve trading liquidity, and increase visibility among long-term institutional investors. As we continue executing our disciplined Solana treasury strategy and compounding SOL-per-share, we believe Forward is well-positioned to establish itself as a leading institutional platform for digital asset exposure.”

The SOL treasury strategy that Navi refers to involves Forward accumulating Solana (SOL) and deploying it through on-chain opportunities, such as staking. Currently, it has liquid SOL holdings of over 7 million SOL and Forward’s validator infrastructure has generated between 6.5% and 7.2% gross annual percentage yield (“APY”) before fees since inception, which outperforms other top peer validators.

Also, around 25% of Forward’s SOL holdings are fwdSOL, which is Forward’s proprietary liquid staking token that lets it maintain liquidity, while earning native staking yield.

About Forward Industries Inc. (NASDAQ: FWDI)

Forward Industries is building and managing a large-scale Solana (SOL) treasury, backed by some of the most influential investors in the digital space. It looks to generate long-term shareholder value through actively participating in the Solana ecosystem. Specifically, it aims to accumulate SOL and strategically deploy assets through various on-chain opportunities like participating in decentralized finance (“DeFi”), staking, and lending.

For more information, visit the Forward Industries website at www.ForwardIndustries.com.

NOTE TO INVESTORS: The latest news and updates relating to FWDI are available in the company’s newsroom at https://ibn.fm/FWDI

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

• ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, just entered into a definitive gold and silver dore purchase agreement with Ocean Partners UK Ltd.
• Ocean Partners will purchase 100% of ESGold’s dore production, in exchange for a non-dilutive working capital facility of up to C$9 million
• Delivery of the dore will be made EXW at the Montauban Project Mine site, with Ocean Partners responsible for collection and related logistics
• The agreement was based on prevailing LBMA or COMEX market prices

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF), a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, just entered into a definitive gold and silver dore purchase agreement with Ocean Partners UK Ltd. With the agreement, Ocean Partners is set to purchase 100% of dore production from ESGold’s flagship Montauban Project. In return, ESGold will gain access to a non-dilutive working capital facility of up to C$9 million (https://ibn.fm/deTSj).

While making the announcement, ESGold’s CEO, Gordon Robb noted just how big of a milestone this is for the company, noting how it marks an evolution from a development company to a near-term producer. “Ocean Partners is an internationally respected organization with extensive experience across metals trading, mine finance, and global mining operations,”  he noted. “Securing a definitive agreement with a group of this caliber significantly strengthens our production strategy and validates the progress our team has made behind the scenes,” he added (https://ibn.fm/deTSj).

The C$9 million in working capital will be available to ESGold in two tranches. The first tranche will come in at C$3 million, with the second at $6 million, subject to satisfaction of applicable conditions precedent. ESGold will retain strategic flexibility regarding timing and use of the facility, however, the agreement outlines a minimum delivery commitment totaling 50,000 ounces of gold and 1,000,000 ounces of silver over the term of the said agreement, as based on projected production scenarios and development plans (https://ibn.fm/deTSj). 

Delivery will be made EXW at the Montauban Project Mine site, with Ocean Partners responsible for collection and related logistics. For ESGold, the arrangement supports operational flexibility, particularly now as the company advances mill construction, commissioning, and production ramp-up activities. 

“What is particularly exciting is the stage we are now entering as a company. While we continue advancing mill construction and infrastructure toward production, we are simultaneously conducting modern exploration and geological investigation at Montauban,” Robb noted. “We are systematically and methodically advancing both sides of the production and exploration story of ESGold at the same time. With the expanded ANT survey underway, drilling preparations advancing, production equipment continuing to arrive on site, and a comprehensive district-scale geological model continuing to evolve,” he added (https://ibn.fm/deTSj). 

This pricing agreement is based on prevailing LBMA or COMEX market prices. Ocean Partners will be paying for 99.8% of contained gold and 99% of contained silver, subject to standard refining charges of US$0.80 per payable ounce of gold and US$0.50 per payable ounce of silver.

For company information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• Humanitas collaboration supports Regentis’ physician adoption strategy and broader commercial infrastructure across the European market.
• GelrinC targets a large orthopedic market that currently lacks an approved off-the-shelf regenerative cartilage repair solution.
• Pivotal FDA enrollment, manufacturing scale-up, physician engagement initiatives and CE Mark status position the company toward multiple potential value-inflection milestones.

Regenerative medicine has long promised to transform patient care, but investors often become most interested when innovative science begins transitioning toward commercial adoption. Regentis Biomaterials (NYSE American: RGNT) is approaching that transition with GelrinC(R), its cartilage regeneration platform targeting a large orthopedic market where treatment alternatives continue to involve meaningful trade-offs. The opportunity is significant. Approximately 470,000 cases of focal knee cartilage damage are treated annually in the United States, yet physicians still lack a broadly available FDA-approved off-the-shelf regenerative cartilage repair solution.  For investors, the central question may be straightforward: what happens if a company successfully introduces a simple regenerative solution into a market where no directly comparable option currently exists?

Beyond the clinical need, GelrinC’s simplicity may prove important from a commercialization standpoint. Unlike more complex cell-based therapies that require tissue harvesting, laboratory processing and multiple procedures, GelrinC is designed for straightforward integration into existing surgical workflows. For investors, that combination of procedural simplicity and regenerative potential could support future physician adoption if clinical and regulatory milestones continue to be achieved 

Clinical results published to date have demonstrated sustained pain relief and functional improvement for more than five years, while imaging assessments suggesting near-complete structural cartilage repair. For investors, these findings are important because they indicate both improved patient outcomes and structural tissue restoration GelrinC has already received CE Mark approval in Europe and is currently being evaluated in a pivotal FDA study that has surpassed 50% enrollment.

Regentis is also taking visible steps toward commercialization. In April 2026, the company announced a collaboration with Humanitas Research Hospital in Milan and cartilage regeneration expert Prof. Elizaveta Kon to support its European Centers of Excellence strategy. Beyond scientific collaboration, these initiatives may help build physician familiarity, surgeon engagement and future adoption pathways ahead of broader commercialization efforts. Operational preparation is advancing as well. Earlier this year, Regentis announced a solvent-free manufacturing process that more than quadrupled GelrinC production yield per batch while improving efficiency and scalability. Although manufacturing developments often receive less attention than clinical milestones, experienced healthcare investors frequently view manufacturing readiness as an important indicator of commercial preparedness Looking ahead, investors may be focused on several potential value inflection events, including completion of pivotal study enrollment, additional clinical follow-up data, regulatory progress, potential PMA submission and continued commercialization initiatives in Europe. Each milestone has the potential to reduce uncertainty and increase investor attention as the company advances toward possible commercialization. Beyond GelrinC itself, the company’s proprietary Gelrin hydrogel platform may also provide future opportunities through additional indications, partnerships or licensing activities.

With regulatory progress, manufacturing scale-up and physician engagement initiatives advancing simultaneously, Regentis appears to be entering a period where execution may become increasingly important to the investment story. As the company moves closer to potential commercialization, investor attention may increasingly focus not simply on whether cartilage regeneration is possible but whether Regentis can successfully convert its clinical foundation into physician adoption, commercial traction and long-term value creation.

For more information, visit the company’s website at www.Regentis.co.il.

NOTE TO INVESTORS: The latest news and updates relating to RGNT are available in the company’s newsroom at ibn.fm/RGNT

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

• The importance of rare earth elements has grown significantly alongside the global energy transition.
• Canamera Energy Metals is accelerating exploration activities at its Turvolândia rare earth project in Minas Gerais, Brazil. 
• The company also filed an independent NI 43-101 technical report for its Jaguaribe rare earth project in Ceará State, Brazil.

Rare earth elements are becoming increasingly essential to the modern global economy, powering technologies that range from electric vehicles and renewable energy systems to advanced defense applications and consumer electronics. As governments and industries push to secure stable supplies of these critical materials outside of dominant supply regions, companies advancing new rare earth projects are drawing heightened attention. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) is positioning itself within that growing strategic landscape through continued progress at its Brazilian rare earth projects, highlighted by recent announcements involving accelerated exploration activities and the filing of an independent technical report.

The importance of rare earth elements has grown significantly alongside the global energy transition. According to the International Energy Agency, critical minerals such as rare earths are essential for technologies tied to electrification, clean energy and advanced manufacturing, with demand expected to rise substantially over the coming decades. Rare earth magnets are used extensively in electric motors, wind turbines and precision electronic systems because of their strength and efficiency.

At the same time, supply-chain concentration remains a major concern. China continues to dominate global rare earth mining and processing capacity, leading western governments and industries to prioritize the development of alternative supply sources. Analysis from the Center for Strategic and International Studies notes that China controls roughly 70% of rare earth mining and approximately 90% of processing capacity, underscoring the strategic importance of projects located in other jurisdictions. This backdrop has increased interest in countries such as Brazil, which hosts significant rare earth potential but remains comparatively underexplored.

Canamera’s recent announcements indicate the company is continuing to move aggressively to expand and define its rare earth assets in Brazil and strengthen its position in the REE space. The company is accelerating exploration activities at its Turvolândia rare earth project in Minas Gerais, Brazil. The company stated that the expanded program is designed to further evaluate ionic clay-hosted rare earth mineralization across the property.

Ionic clay deposits are especially significant within the rare earth industry because they can often be processed using relatively simpler and lower-cost extraction methods compared with hard rock rare earth deposits. Brazil has increasingly attracted attention for this type of mineralization because some of its geological formations resemble the ionic clay systems historically developed in southern China.

Canamera’s announcement noted that the accelerated exploration program follows encouraging early drilling and sampling results at Turvolândia. The company stated that it plans to increase auger drilling density, expand target areas and continue metallurgical and geological evaluation work. This type of systematic exploration approach is important because it allows the company to better define the scale, continuity and characteristics of the mineralized zones.

Canamera also filed an independent NI 43-101 technical report for its Jaguaribe rare earth project in Ceará State, Brazil. Technical reports prepared under NI 43-101 standards are significant milestones for mineral exploration companies because they provide independently reviewed geological and technical information intended to meet regulatory disclosure standards.

According to the company, the report supports the geological prospectivity of the Jaguaribe property and provides additional technical context regarding the project’s rare earth mineralization potential. Independent reports can help strengthen the credibility of exploration programs by providing outside verification and analysis of project data.

Together, these two developments suggest Canamera is advancing along multiple fronts simultaneously. The company is not only continuing active field exploration at Turvolândia but also formalizing technical documentation and disclosure around Jaguaribe. This combination of ongoing exploration and technical advancement reflects a broader effort to build a diversified rare earth portfolio in Brazil.

The company’s strategy appears aligned with growing geopolitical and industrial trends favoring diversified rare earth supply chains. As demand for magnet rare earth elements increases, governments and manufacturers are seeking supply relationships that reduce dependence on highly concentrated processing regions. Projects located in jurisdictions with supportive geology and mining potential may therefore become increasingly important to global supply diversification efforts.

Canamera’s focus on ionic clay-hosted rare earth mineralization may also prove strategically important. Ionic clay systems are viewed favorably because of their potential for simpler extraction processes and lower-cost development compared with more complex hard rock projects. Successful development of these types of deposits outside China could help broaden global rare earth supply options.

The company’s recent announcements also indicate that management is working to advance projects through multiple stages of evaluation and development rather than relying solely on conceptual exploration. Accelerating field programs, increasing drilling activity and filing independent technical reports are all steps commonly associated with building project credibility and preparing for longer-term advancement.

As the rare earth sector continues evolving, companies capable of demonstrating both geological potential and systematic project advancement are likely to attract increasing attention from investors and industry participants. Canamera Energy Metals’ recent progress in Brazil reflects this broader trend, positioning the company within a rapidly growing segment of the critical minerals industry.

With rare earth demand continuing to expand alongside electrification, renewable energy deployment and advanced technology manufacturing, the strategic value of new rare earth projects may continue rising. Through its exploration efforts at Turvolândia and its advancing technical work at Jaguaribe, Canamera Energy Metals is working to establish itself as part of the next generation of non-Chinese rare earth development companies.

For more information, visit the company’s website at CanameraMetals.com. 

NOTE TO INVESTORS: The latest news and updates relating to EMETF are available in the company’s newsroom at ibn.fm/EMETF

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This document contains “forward-looking information” within the meaning of applicable securities legislation, including statements regarding: the Company’s planned exploration activities on its projects; the anticipated timing and completion of the earn-in milestones under the Option Agreement; the Company’s ability to make required cash and share payments and incur required exploration expenditures; the geological prospectivity of its projects; and the Company’s exploration strategy.

Forward-looking information is based on assumptions, estimates, and opinions of management at the date the statements are made and is subject to a variety of risks and uncertainties that could cause actual results to differ materially from those anticipated or projected. These assumptions include, without limitation: the Company’s ability to raise sufficient capital to fund its exploration programs and option payments; favourable regulatory conditions; continued access to its projects; and general economic conditions.

Important risk factors that could cause actual results to differ materially include, but are not limited to: uncertainties related to raising sufficient financing; the inherently speculative nature of mineral exploration; title risks; environmental and permitting risks; and fluctuations in uranium prices. Additional risk factors affecting the Company can be found in the Company’s continuous disclosure documents available at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on forward-looking information.

• Earth Science Tech has evolved into a diversified healthcare holding company with operations spanning telemedicine, compounding pharmacies, clinical support services and healthcare fulfillment.
• In addition, the company has actively reduced its share count through a series of share repurchases documented in SEC filings and share structure records.
• Earth Science Tech repurchased 3.7 million shares over the nine months ended December 31, 2025, spending approximately $647,000.
• Management continues to emphasize shareholder value through balance-sheet management alongside acquisitions and operating growth.
• The company is scheduled to present to investors at the Planet MicroCap Las Vegas 2026 conference in June.

For many investors evaluating companies on the OTC market, share structure often receives as much attention as revenue growth or acquisition activity. Earth Science Tech (OTC: ETST), a strategic holding company spanning telemedicine, pharmacies, clinical support services, and healthcare fulfillment, has increasingly distinguished itself in share structure and financial stability through a sustained program of share repurchases, which has reduced outstanding shares while the company simultaneously expands its healthcare-focused operating platform.

The company’s most recent Form 10-Q, covering the quarter ended December 31, 2025, provides a detailed look at the pace of those repurchases (https://ibn.fm/Gm12j). According to the filing, Earth Science Tech repurchased 1,143,000 common shares during the quarter for approximately $177,659 through private transactions with shareholders. The purchases included 380,000 shares acquired on October 28, 2025, at $0.08 per share and an additional 763,000 shares purchased on December 10, 2025, at $0.193 per share.

The buyback activity extends well beyond a single quarter. For the nine months ended December 31, 2025, the company reported repurchasing 3,703,296 shares for a total cost of approximately $647,087. Those transactions included purchases of 1,050,296 shares in April 2025, 1,510,000 shares in September 2025, 380,000 shares in October 2025 and 763,000 shares in December 2025.

The significance of those repurchases becomes more apparent when compared with the company’s current share structure. Earth Science Tech reported 290.6 million shares outstanding as of June 1, 2026. The same data shows a reduction of approximately 715,000 shares during the most recent three-month period, a decline of 1.8 million shares over six months and a decrease of approximately 3.69 million shares over the last twelve months. Those figures closely mirror the repurchase activity disclosed in SEC filings (https://ibn.fm/cxJkG). 

The historical share structure data also provides a timeline of share reductions. Outstanding shares declined from more than 294.3 million in September 2025 to approximately 290.6 million by June 2026, reflecting a series of cancellations and repurchases over that period.

For investors accustomed to seeing microcap companies expand share counts through repeated equity issuance, Earth Science Tech’s approach stands out. The company maintains 300 million authorized shares, leaving relatively limited separation between authorized and outstanding stock. As of June 2026, approximately 215.1 million shares were classified as restricted, while the public float stood at roughly 40.8 million shares.

While share repurchases alone do not determine investment performance, they can provide insight into management’s capital allocation priorities. In ETST’s case, the reduction in outstanding shares suggests an emphasis on preserving shareholder ownership percentages while executing a broader corporate growth strategy.

The company’s growth strategy has successfully evolved over the past several years, transitioning away from its legacy wellness operations and repositioning itself as a diversified holding company focused primarily on healthcare-related businesses. The company now operates through subsidiaries involved in pharmaceutical compounding, telemedicine, clinical support services, healthcare fulfillment, real estate investments and cash management activities.

The central theme behind the model is vertical integration. Management has assembled businesses that participate in multiple stages of the patient-care process, from initial consultation and telehealth interactions to prescription fulfillment and ongoing support services. Telemedicine platforms serve as a front-end entry point for patients seeking medical consultations and treatment options. Compounding pharmacies then provide customized prescription fulfillment, creating recurring interactions that can extend over long periods.

By integrating these functions internally, the company seeks to capture value across multiple stages of the healthcare continuum rather than relying on a single revenue stream. The structure offers exposure to sectors that continue to benefit from long-term healthcare demand trends, including personalized medicine, telehealth adoption and outpatient care delivery.

At the same time, management has continued emphasizing financial discipline. The share repurchase program demonstrates a willingness to deploy capital toward reducing share count while pursuing operating expansion. That balance between acquisition-driven growth and shareholder-focused capital management has become a recurring theme in company communications.

Regarding investor visibility, the company announced that Chairman and Chief Executive Officer Giorgio R. Saumat will present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17 at the Bellagio Resort & Hotel. The event, organized in conjunction with MicroCapClub, brings together microcap companies and investors for presentations and one-on-one meetings. The conference appearance offers management an opportunity to discuss the company’s operating strategy, healthcare platform and capital allocation priorities directly with investors.

For shareholders, however, one of the clearest signals may already be visible in the numbers. While many small-cap and OTC companies face scrutiny over expanding share counts, Earth Science Tech’s recent filings and share structure records show a different pattern. More than 3.7 million shares were repurchased during the nine months ended December 2025, and the company’s outstanding share count has continued trending lower into 2026.

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST